David Loew
Chief Executive Officer at IPSEN
Net worth: 61 001 $ as of 2024-04-29
David Loew active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IPSEN | Director/Board Member | 2020-06-30 | - |
| Chief Executive Officer | 2020-06-30 | - | |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Chairman | 2020-07-29 | - |
| European Federation of Pharmaceutical Industries & Assoc | Director/Board Member | - | - |
| G5 Santé | Director/Board Member | - | - |
Career history of David Loew
Former positions of David Loew
| Companies | Position | Start | End |
|---|---|---|---|
| SANOFI | Corporate Officer/Principal | 2013-06-30 | 2020-06-14 |
| GAVI Alliance | Director/Board Member | - | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | 2013-06-30 | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Training of David Loew
| University of St. Gallen | Masters Business Admin |
Statistics
International
| France | 5 |
| Switzerland | 4 |
| United States | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 5 |
| Commercial Services | 3 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| SANOFI | Commercial Services |
| IPSEN | Health Technology |
| ROCHE HOLDING AG | Health Technology |
| Private companies | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
| GAVI Alliance | Miscellaneous |
| European Federation of Pharmaceutical Industries & Assoc | Commercial Services |
| G5 Santé |
- Stock Market
- Insiders
- David Loew
- Experience